3.8 Article

A phase I/II study of stereotactic radiotherapy and pembrolizumab for oligometastatic renal tumours (RAPPORT): Clinical trial protocol

Related references

Note: Only part of the references are listed.
Article Medicine, General & Internal

Pembrolizumab plus Axitinib versus Sunitinib for Advanced Renal-Cell Carcinoma

Brian I. Rini et al.

NEW ENGLAND JOURNAL OF MEDICINE (2019)

Article Medicine, General & Internal

Nivolumab plus Ipilimumab versus Sunitinib in Advanced Renal-Cell Carcinoma

R. J. Motzer et al.

NEW ENGLAND JOURNAL OF MEDICINE (2018)

Review Urology & Nephrology

Radiotherapy for renal cell carcinoma: renaissance of an overlooked approach

Shankar Siva et al.

NATURE REVIEWS UROLOGY (2017)

Review Urology & Nephrology

Is observation a valid strategy in metastatic renal cell carcinoma?

Lisa M. Pickering et al.

CURRENT OPINION IN UROLOGY (2015)

Article Medicine, General & Internal

Nivolumab versus Everolimus in Advanced Renal-Cell Carcinoma

R. J. Motzer et al.

NEW ENGLAND JOURNAL OF MEDICINE (2015)

Article Oncology

PD-1 Restrains Radiotherapy-Induced Abscopal Effect

Sean S. Park et al.

CANCER IMMUNOLOGY RESEARCH (2015)

Article Medicine, Research & Experimental

Irradiation and anti-PD-L1 treatment synergistically promote antitumor immunity in mice

Liufu Deng et al.

JOURNAL OF CLINICAL INVESTIGATION (2014)

Article Oncology

International Spine Radiosurgery Consortium Consensus Guidelines for Target Volume Definition in Spinal Stereotactic Radiosurgery

Brett W. Cox et al.

INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2012)

Article Cardiac & Cardiovascular Systems

Can we predict long-term survival after pulmonary metastasectomy for renal cell carcinoma?

SC Murthy et al.

ANNALS OF THORACIC SURGERY (2005)